ANDA 88308, held by Sandoz. Thioridazine Hydrochloride.
As of Nov 15, 2026, ANDA 88308 (Thioridazine Hydrochloride), held by Sandoz, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride100MG/ML ยท concentrate;oral | Thioridazine Hydrochloride | Discontinued |
| Jul 25, 1984 | Supplement 2Manufacturing | Approved | None posted |
| Mar 21, 1984 | Supplement 5Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
